MD2-TLR4-IN-1 mitigates synuclein preformed fibril-mediated inflammatory response in microglia: insights from an in vitro and in vivo study.

Singh G, Dalal A, Kalia NP

Open source

DOI
10.1080/08923973.2026.2746670
Published
2026 Nov 10
Container
Immunopharmacology and immunotoxicology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/08923973.2026.2746670,
  title = {MD2-TLR4-IN-1 mitigates synuclein preformed fibril-mediated inflammatory response in microglia: insights from an in vitro and in vivo study.},
  author = {Singh G and Dalal A and Kalia NP},
  year = {2026},
  journal = {Immunopharmacology and immunotoxicology},
  doi = {10.1080/08923973.2026.2746670},
  url = {https://doi.org/10.1080/08923973.2026.2746670}
}

RIS

TY  - JOUR
TI  - MD2-TLR4-IN-1 mitigates synuclein preformed fibril-mediated inflammatory response in microglia: insights from an in vitro and in vivo study.
AU  - Singh G
AU  - Dalal A
AU  - Kalia NP
PY  - 2026
JO  - Immunopharmacology and immunotoxicology
DO  - 10.1080/08923973.2026.2746670
UR  - https://doi.org/10.1080/08923973.2026.2746670
ER  - 

APA

G, S., A, D., & NP, K. (2026). MD2-TLR4-IN-1 mitigates synuclein preformed fibril-mediated inflammatory response in microglia: insights from an in vitro and in vivo study.. Immunopharmacology and immunotoxicology. https://doi.org/10.1080/08923973.2026.2746670

Source records